As Crestor Patent Trial Nears, Generic Firms Seek To Block AstraZeneca Subsidiary From Suit
This article was originally published in The Pink Sheet Daily
Executive Summary
Defendants in infringement case claim AstraZeneca Pharmaceuticals LP has no rights to the patent at issue.